Opus Genetics, Inc.
IRD
35 insider filings · Latest: Sep 30, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 2 11:47 PM | Foundation Fighting Blindness Retinal Degeneration FundDirector, Other | Sale | 556,000 | $4.96 | $2.8M | 3,236,171(D) | View → |
| Sep 3, 2026 | Sep 8 8:05 PM | Robert E. GagnonChief Financial Officer | Sale | 28,000 | $4.54 | $127.2K | 556,375(D) | View → |
| Sep 3, 2026 | Sep 3 8:11 PM | Gagnon Robert E. | Proposed Sale | 28,000 | $4.45 | $124.6K | — | View → |
| Jul 23, 2026 | Jul 27 8:08 PM | Benjamin R YerxaDirector, President | Sale | 7,429 | $2.97 | $22.1K | 704,106(D) | View → |
| Jul 23, 2026 | Jul 27 8:07 PM | Joseph K SchachleChief Operating Officer | Sale | 4,644 | $2.94 | $13.7K | 291,440(D) | View → |
| Jul 23, 2026 | Jul 27 8:07 PM | George MagrathDirector, Chief Executive Officer | Sale | 9,475 | $2.95 | $27.9K | 1,731,869(D) | View → |
| Jul 23, 2026 | Jul 27 8:06 PM | Robert E. GagnonChief Financial Officer | Sale | 7,783 | $2.95 | $22.9K | 584,375(D) | View → |
| Jul 23, 2026 | Jul 23 9:21 PM | Gagnon Robert E. | Proposed Sale | 7,783 | $3.05 | $23.7K | — | View → |
| Jul 23, 2026 | Jul 23 9:17 PM | Magrath George | Proposed Sale | 9,475 | $3.05 | $28.9K | — | View → |
| Jul 23, 2026 | Jul 23 5:09 PM | SCHACHLE JOSEPH K | Proposed Sale | 4,644 | $2.94 | $13.7K | — | View → |
| Jul 23, 2026 | Jul 23 4:46 PM | YERXA BENJAMIN R | Proposed Sale | 7,429 | $2.97 | $22.1K | — | View → |
| May 18, 2026 | May 20 11:29 PM | Foundation Fighting Blindness Retinal Degeneration FundDirector, Other | Sale | 1,700,000 | $4.35 | $7.4M | 3,792,171(D) | View → |
| Apr 23, 2026 | Apr 27 8:28 PM | Benjamin R YerxaDirector, President | Sale | 7,470 | $5.24 | $39.1K | 711,535(D) | View → |
| Apr 23, 2026 | Apr 27 8:28 PM | Joseph K SchachleChief Operating Officer | Sale | 4,697 | $5.22 | $24.5K | 296,084(D) | View → |
| Apr 23, 2026 | Apr 27 8:27 PM | Rabourn Amy ZarembaHead of Fin. Quality Assurance | Sale | 1,641 | $5.20 | $8.5K | 188,671(D) | View → |
| Apr 23, 2026 | Apr 27 8:27 PM | George MagrathDirector, Chief Executive Officer | Sale | 9,511 | $5.22 | $49.6K | 1,741,344(D) | View → |
| Apr 23, 2026 | Apr 27 8:26 PM | Ashwath JayagopalChief Scientific & Dev. Ofc. | Sale | 7,542 | $5.19 | $39.2K | 509,233(D) | View → |
| Apr 23, 2026 | Apr 27 8:26 PM | Robert E. GagnonChief Financial Officer | Sale | 7,842 | $5.18 | $40.7K | 592,158(D) | View → |
| Apr 23, 2026 | Apr 23 10:11 PM | SCHACHLE JOSEPH K | Proposed Sale | 4,697 | $5.22 | $24.5K | — | View → |
| Apr 23, 2026 | Apr 23 9:55 PM | YERXA BENJAMIN R | Proposed Sale | 7,470 | $5.24 | $39.1K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 9, 2026 | Sep 11 8:09 PM | George MagrathDirector, Chief Executive Officer | Option Exercise | 392,157 | $1.15 | 0(D) | View → |
| Sep 8, 2026 | Sep 8 8:05 PM | Cam GallagherDirector | Option Exercise | 784,314 | $1.15 | 0(D) | View → |